CONSUMER NEWS    RECALLS    COMPLAINT FORM    SCAM ALERTS  


Complain about a product or service

Small Claims Guide | Class Actions | Lemon Law | FAQ | Resources | Newsletters | Spanish
Automotive    Education    Electronics    Family    Finance    Health    Homeowners    Shopping    Travel   
NEWS   Latest |  Archives |  Auto |  Cells, etc. |  Computers |  Financial |  Health |  Homeowners |  Parents |  Privacy |  Scams |  Seniors |  Travel

Doctors' Drug Explanations Faulted

Study Finds Many Doctors Don't Adequately Communicate with Patients





September 25, 2006

Drug Safety
Feds Seize More Than $24 Million in Unapproved New Drugs
Consumers Increasingly Exposed to Counterfeit Drugs
FDA Wants Black Box Warning on Antibiotics
Public Citizen Sues FDA for Failure to Act on Darvon
FDA Probes Arthritis Drug Link To Cancer
FDA Wants New Labeling Rules To Protect Pregnant, Nursing Women
Anti-Smoking Drug Chantix Linked to Seizures, Heart Problems, Diabetes
Bayer Pulls Trasylol From Market
MIT Researchers Confirm Contamination in Heparin
Be Careful Using Over-the-Counter Creams, Ointments
Another Heparin Producer Announces a Recall
FDA Moves Closer To Setting Up Shop In China
Study Raises Concerns About Anemia Drugs
Congress Hears Warnings about FDA
China Connection in Heparin Problems?
Heparin Linked to Severe Allergic Reactions
Antibiotic Leads to Tendon Ruptures
Second Safety Warning on Fentanyl Skin Patch
Merck Recalls Children's Vaccines
Study: Avandia May Do More Harm than Good
Texas Sues Drug Manufacturer Blamed for West Coast Deaths
Bayer Withdraws Antibleeding Drug Trasylol
---
More drug safety news ...

Doctors prescribing new medication often do not communicate to patients important details, such as potential side effects, how long or how often to take the drug or the specific name of the medication, according to an article in the current issue of Archives of Internal Medicine.

Almost half of all Americans take at least one prescription drug, and half of older adults take three or more. Taking medications properly is essential in ensuring their effectiveness.

However, patients often do not adhere to prescribed therapies, which can lead to worsening disease, failure of the treatment, adverse effects, drug overdose, unnecessary hospitalization and higher health care costs.

"Patients who report better general physician communication, better explanations about how to take their medications and more medication information are more adherent," the authors write. "One-on-one educational interventions can improve patient adherence and health outcomes."

Derjung M. Tarn, M.D., Ph.D., of the David Geffen School of Medicine, University of California, Los Angeles, and colleagues assessed communication by physicians prescribing new medications in 185 outpatient visits with 44 physicians in 1999.

Patients were called one to two days prior to their appointments at one of two health care systems in Sacramento, Calif. Their encounters with the physicians were then audiotaped and transcribed, and physicians identified those at which new medications were prescribed.

The researchers coded the transcripts for the type of communication that occurred, based on five key recommended elements: the name of the medication, the purpose or justification for taking it, the duration of use, adverse effects and the number of tablets or sprays plus the frequency or timing of ingestion.

A total of 243 new medications were prescribed at visits monitored during the study, including 46 cardiovascular medications; 42 ear, nose and throat preparations; 35 analgesics (pain-relieving drugs); 35 antibiotics; 21 dermatologic creams; 21 psychiatric medications; and 11 pulmonary medications.

Overall, physicians communicated an average of 3.1 of the five essential elements, indicating that 62 percent of the necessary information was conveyed. Physicians used the specific name for 74 percent of new prescriptions, explained the purpose for 87 percent and discussed adverse effects for 35 percent.

Thirty-four percent of the encounters included instructions on how long to take the drug, 55 percent on the number of tablets to take and 58 percent on the frequency or timing of dosing.

"This study demonstrates spotty physician counseling about new medication prescriptions," the authors write.

"Although physicians educated patients more about psychiatric and analgesic medications, the overall quality of communication was poor even for these medication types and could contribute to patient misunderstandings about how and why to take their new medications. Physicians conveyed full medication dosing directions for less than 60 percent of all medications and informed patients about duration of intake and adverse effects or adverse events only approximately one-third of the time."

Patients receiving incomplete instructions may be less likely to take their medication properly, in part because they do not understand how to do so, they conclude. However, patients often get medication information from pharmacists and other sources, and there may be trade-offs involved to asking physicians to provide more detailed communication.

"More research is needed to investigate how much time physicians spend educating patients about new medications and whether better communication is associated with more appropriate patient medication use and health outcomes," they write.



Report Your Experience
If you've had a bad experience -- or a good one -- with a consumer product or service, we'd like to hear about it. All complaints are reviewed by class action attorneys and are considered for publication on our site. Knowledge is power! Help spread the word. File your consumer report now.


Consumer News

August 29 2008

Recent Recalls & Safety Alerts



FREE CONSUMER NEWSLETTERS

The Daily Consumer
Afternoons M-F

Sign up now!


Consumer News & Alerts
Every Sunday

Sign up now!


Knowledge is free.
Knowledge is power.







Back to the top |

Advertisement


Home | Complaint Form | News | Recalls | FAQ |
Consumer Resources | Small Claims Guide | Lemon Law | Newsletter | Contact Us
Advertise With Us | Testimonials | Newsroom | RSS Feeds |


Terms of Use Your use of this site constitutes acceptance of the Terms of Use

Advertisements on this site are placed and controlled by outside advertising networks. ConsumerAffairs.com does not evaluate or endorse the products and services advertised. See the FAQ for more information.

Company Response Welcome If complaints about your company appear on our site, we welcome your response. Please see the Response Form for more information.

For more information, see the FAQ and privacy policy. The information on this Web site is general in nature and is not intended as a substitute for competent legal advice.  ConsumerAffairs.com Inc. makes no representation as to the accuracy of the information herein provided and assumes no liability for any damages or loss arising from the use thereof. 

Copyright © 2003-2008 ConsumerAffairs.com Inc.  All Rights Reserved.    The contents of this site may not be republished, reprinted, rewritten or recirculated without written permission.